payday loans
wholesale jerseys
Skip to content

Accueil Managing Asthma in Pregnancy (MAP) trial: FeNO levels and childhood asthma
Managing Asthma in Pregnancy (MAP) trial: FeNO levels and childhood asthma Imprimer Envoyer
Samedi, 17 Mars 2018 06:55
The single-centre double-blind, randomised controlled Managing Asthma in Pregnancy (MAP) trial in Newcastle, Australia, compared a treatment algorithm using the fraction of exhaled nitric oxide (FeNO) in combination with asthma symptoms (FeNO group) against a treatment algorithm using clinical symptoms only (clinical group) in pregnant asthmatic women (ANZ Clinical Trials Registry, number 12607000561482). The primary outcome was a 50% reduction in asthma exacerbations during pregnancy in the FeNO group.

Author:Matthew Morten, Adam Collison, Vanessa E. Murphy, Daniel Barker, Christopher Oldmeadow, John Attia, Joseph Meredith, Heather Powell, Paul D. Robinson, Peter D. Sly, Peter G. Gibson, Joerg Mattes

Read Full Article
 

find-us-on-facebook-2

United4LungHealth

image001

World Allergy Week 2017 The Agony of Hives

WCOPDday2017



PubMed Logo
Word

 To: 

Langtolang Dictionary

CNP2017

50x50_firefoxsafari_iconGchrome

Notre site est optimisé pour les Navigateurs suivants : Firefox, Safari et Google Chrome. Cliquez sur l'un des logos ci-dessus pour le télécharger et l'installer gratuitement.

Tabac

Accueil Managing Asthma in Pregnancy (MAP) trial: FeNO levels and childhood asthma Top